Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease

NCT05014555 · clinicaltrials.gov ↗

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Diseases

Interventions

BIOLOGICAL: COVID-19 Vaccine

Sponsor

GI Alliance

Collaborators

[object Object]
[object Object]
[object Object]